Skip to main content
SpringerLink
Log in

Stürze und eine Demenz sind keine Kontraindikation für eine orale Antikoagulation bei älteren Patienten mit Vorhofflimmern

Falls and dementia are not contraindications for anticoagulation in older adults with atrial fibrillation

  • Leserbrief
  • Published:
Zeitschrift für Gerontologie und Geriatrie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bahrmann P, Wehling M, Ropers D, Flohr J, Leischker A, Röther J (2015) Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel. Drug Res (Stuttg) 65(10):505–514

    CAS  Google Scholar 

  2. Gosch M, Roller RE, Böhmdorfer B, Benvenuti-Falger U, Iglseder B, Lechleitner M, Sommeregger U, Dovjak P (2012) Management and therapy of atrial fibrillation in geriatric patients. Z Gerontol Geriatr 45(1):55–66

    Article  CAS  PubMed  Google Scholar 

  3. Suárez FC, Formiga F, Camafort M, Cepeda RM, Díez-Manglano J, Pose RA, Tiberio G, Mostaza JM, Grupo de trabajo de Riesgo vascular de la SEMI (2015) Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach. BMC Cardiovasc Disord 15:143 (Erratum in: BMC Cardiovasc Disord 2015;15(1):157). doi:10.1186/s12872-015-0137-7

    Article  Google Scholar 

  4. Zarraga IG, Kron J (2013) Oral anticoagulation in elderly adults with atrial fibrillation: integrating new options with old concepts. J Am Geriatr Soc 61(1):143–150

    Article  PubMed  Google Scholar 

  5. Bond AJ, Molnar FJ, Li M, Mackey M, Man-Son-Hing M (2005) The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy. Thromb J 3(1):1

    Article  PubMed  PubMed Central  Google Scholar 

  6. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) ESC committee for practice guidelines-CPG; document reviewers. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation–developed with the special contribution of the European heart rhythm association. Europace 14(10):1385–1413

    Article  PubMed  Google Scholar 

  7. Friberg L, Rosenqvist M, Lip GY (2012) Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 125(19):2298–2307

    Article  CAS  PubMed  Google Scholar 

  8. Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, Granger CB, Hanna M, Held C, Husted S, Hylek EM, Jansky P, Lopes RD, Ruzyllo W, Thomas L, Wallentin L (2014) Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. Eur Heart J 35(28):1864–1872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Inui TS, Parina R, Chang DC, Inui TS, Coimbra R (2014) Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit. J Trauma Acute Care Surg 76(3):642–649 (discussion 649–650)

    Article  CAS  PubMed  Google Scholar 

  10. Man-Son-Hing M, Nichol G, Lau A, Laupacis A (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159(7):677–685

    Article  CAS  PubMed  Google Scholar 

  11. Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26(8):1471–1477

    Article  CAS  PubMed  Google Scholar 

  12. Bahri O, Roca F, Lechani T, Druesne L, Jouanny P, Serot JM, Boulanger E, Puisieux F, Chassagne P (2015) Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude. J Am Geriatr Soc 63(1):71–76

    Article  PubMed  Google Scholar 

  13. Poggesi A, Inzitari D, Pantoni L (2015) Atrial fibrillation and cognition: epidemiological data and possible mechanisms. Stroke 46(11):3316–3321

    Article  PubMed  Google Scholar 

  14. Steinberg BA, Greiner MA, Hammill BG, Curtis LH, Benjamin EJ, Heckbert SR, Piccini JP (2015) Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation. Cardiovasc Ther 33(4):177–183

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik 2 – Geriatrie, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität Nürnberg, Prof. Ernst-Nathan-Str. 1, 90419, Nürnberg, Deutschland

    M. Gosch

  2. Universitätsklinik für Geriatrie, Christian-Doppler-Klinik, Paracelsus Medizinische Privatuniversität, Salzburg, Österreich

    B. Iglseder

  3. Klinik für Geriatrie, HELIOS Klinikum Schwelm, Schwelm, Deutschland

    H. J. Heppner

  4. Lehrstuhl Geriatrie, Universität Witten/Herdecke, Schwelm, Deutschland

    H. J. Heppner

Authors
  1. M. Gosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Iglseder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. J. Heppner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Gosch.

Ethics declarations

Interessenkonflikt

M. Gosch erhielt Referenten-/Beraterhonorare von AO-Foundation, BMS, Lilly, MSD, Novartis, Otsuka, Pfizer Pharma GmbH. B. Iglseder erhielt Referentenhonorare von Pfizer Pharma GmbH, Bayer Healthcare, Lilly und EVER-Neuropharma. H.J. Heppner erhielt Referentenhonorare von Pfizer Pharma GmbH, Bayer Healthcare, Sanofi und Astellas Pharma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gosch, M., Iglseder, B. & Heppner, H.J. Stürze und eine Demenz sind keine Kontraindikation für eine orale Antikoagulation bei älteren Patienten mit Vorhofflimmern. Z Gerontol Geriat 49, 458–459 (2016). https://doi.org/10.1007/s00391-016-1088-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00391-016-1088-z

Search

Navigation